Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections
Status unconfirmed
Conditions studied: Nosocomial Bacteremia, MRSA Colonization, MRSA Infection, VRE Colonization, VRE Infection
In brief
To determine if daily bathing with chlorhexidine impregnated washcloths will reduce the incidence of MRSA and VRE within an Intensive Care Unit (ICU) or ward setting.
Key facts
- Study ID
- NCT00502476
- Run by
- Hunter Holmes Mcguire Veteran Affairs Medical Center
- People needed
- 14000
- Starts
- 2007-08-01
- Expected to finish
- 2009-09-01
- Last updated by the study team
- 2007-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients admitted to study units during the proposed study interval are eligible for inclusion in the study
You may not qualify if…
- Patients with known allergies to chlorhexidine gluconate or any other ingredients in the product
- Patients with burns that include a high percentage of disrupted body surface area
- Use in patients undergoing lumbar punctures or contact with the meninges
- Patients with large open skin wounds; and
- Children less than 18 years old
Where it is running
- Hunter Holmes McGuire Veteran Affairs Medical Center — Richmond, Virginia, United States (enrolling)
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- Barnes Jewish Hospital — St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.